Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Yarrow Bioscience, Inc (YARW)

Compass Therapeutics, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Compass Therapeutics, Inc. and Yarrow Bioscience, Inc are of similar size ($147.2M and $136.7M). Compass Therapeutics, Inc. has the higher net margin (0.00% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Compass Therapeutics, Inc. leads on 7 and Yarrow Bioscience, Inc on 5.

Valuation

Metric CMPX YARW Biotechnology median
P/E n/m n/m 10.60
P/S n/m 27.77 9.40
P/B 0.86 0.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.40 n/m 0.66
EV/Sales n/m 118.48 9.02
Earnings yield (52.63%) (138.76%) (32.88%)
Free cash flow yield (39.71%) (127.91%) (23.13%)

Profitability

Metric CMPX YARW Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (4,134.44%) 0.00%
Net margin 0.00% (3,881.54%) 0.00%
Free cash flow margin 0.00% (3,513.07%) 0.00%
Return on equity (56.66%) (61.40%) (51.96%)
Return on assets (47.87%) (54.77%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX YARW Biotechnology median
Revenue growth (TTM) — 1.26% 6.76%
EPS growth (last fiscal year) (16.67%) 32.26% 29.88%
Revenue growth, 5-year CAGR — (51.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX YARW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 15.26 4.97
Net debt to EBITDA 2.86 0.95 1.01

Dividend

Metric CMPX YARW Biotechnology median
Dividend yield — 0.10% 0.41%
Payout ratio — — —

Size

Metric CMPX YARW Biotechnology median
Market cap 136.65m 147.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack